|
|
|
10.11.26 - 12:03
|
Lundbeck raises financial guidance for 2026 (PR Newswire)
|
|
|
VALBY, Denmark, Nov. 10, 2026 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) raises its full-year 2026 guidance for revenue and adjusted EBITDA growth at constant exchange rates (CER). Lundbeck has increased its 2026 revenue outlook, primarily reflecting the continued strong performance of......
|
|
|
10.11.26 - 11:42
|
Lundbeck raises full-year guidance as 9M revenue grows +13% CER (+11% CER underlying) and adjusted EBITDA +19% CER, led by Vyepti[®] (Cision)
|
|
|
Key highlights
Lundbeck's total revenue grew by +13% CER[1] (+9% DKK) to DKK 20,191 million in the first nine months of 2026, with all regions contributing to the growth. The performance reflected strong Vyepti[®] growth, supported by solid contributions from Rexulti[®] and focused commercial execution across key markets. The transition to a partnership model in 27 markets[2] continued to progress according to plan, supporting Lundbeck's strategic focus. Adjusting for the planned one-time DKK 470 million inventory build in these markets in the first quarter of 2026, total underlying...
|
|
|
27.10.26 - 15:03
|
Laxxon Medical Appoints Matthew Cascio as Vice President and Head of Business Development (Business Wire)
|
|
|
Pharmaceutical business development leader to drive strategic partnerships and advance commercial opportunities for Laxxon's SPID® drug-delivery technology.NEW YORK--(BUSINESS WIRE)--Laxxon Medical today announced the appointment of Matthew Cascio as Vice President and Head of Business Development. Cascio brings more than 20 years of global pharmaceutical industry experience spanning corporate development, strategic licensing, research collaborations, and commercial and scientific evaluation of pharmaceutical assets.
Cascio joins Laxxon from Amneal Pharmaceuticals, where he most recently served as Senior Director of Corporate Development and Head of Specialty Business Development. Previously, he spent more than a decade at Lundbeck in corporate business development and strategy roles, contributing to transactions spanning licensing agreements, mergers & acquisitions, asset acquisitions, equity investments, and research collaborations. Throughout his career, he has led or contributed to more than 60 comp...
|
|
|
|
|
|
|
18.10.26 - 19:45
|
Changes to the Board of Directors of H. Lundbeck A/S (PR Newswire)
|
|
|
Dorothea Wenzel, Chair of the Board, has informed the Board that she will step down in connection with the Annual General Meeting in 2027. Following the AGM, Lundbeck's Board intends to appoint Lars Fruergaard Jørgensen as the new Chair. Effective 10 November 2026, Lars Fruergaard......
|
|
|
18.10.26 - 19:42
|
Changes to the Board of Directors of H. Lundbeck A/S (PR Newswire)
|
|
|
Dorothea Wenzel, Chair of the Board, has informed the Board that she will step down in connection with the Annual General Meeting in 2027. Following the AGM, Lundbeck's Board intends to appoint Lars Fruergaard Jørgensen as the new Chair. Effective 10 November 2026, Lars Fruergaard......
|
|
|
18.10.26 - 18:01
|
Changes to the Board of Directors of H. Lundbeck A/S (Cision)
|
|
|
· Dorothea Wenzel, Chair of the Board, has informed the Board that she will step down in connection with the Annual General Meeting in 2027.
· Following the AGM, Lundbeck's Board intends to appoint Lars Fruergaard Jørgensen as the new Chair.
· Effective 10 November 2026, Lars Fruergaard Jørgensen will join the Board as an observer, until the formal election.
H. Lundbeck A/S (Lundbeck) announces that Dorothea Wenzel has informed Lundbeck's Board of Directors (Board) that she will step down in connection with the Annual General Meeting (AGM) in 2027. Dorothea joined the Lundbeck...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28.09.26 - 08:30
|
Lars Bang, Executive Vice President, Product Development & Supply, has passed away (Cision)
|
|
|
Valby, Denmark, 28 September, 2026 – H. Lundbeck A/S (Lundbeck)
It is with profound sadness that we share that Lars Bang, Executive Vice President, Product Development & Supply, has passed away.
Lars joined Lundbeck in 1988 and dedicated almost four decades of his professional life to the company. During that time, he held a number of senior leadership positions across Lundbeck spanning R&D, corporate strategy, international sales and marketing, and production and supply. From 2003, Lars held senior leadership responsibility for our production and supply organization, most recently...
|
|
|
|
|
21.09.26 - 16:24
|
Correction - Transactions with shares and linked securities in Lundbeck made by executives and their closely associated parties (Cision)
|
|
|
H. Lundbeck A/S (Lundbeck) hereby publishes and reports a correction to a previous notification on transactions made by executives and persons closely associated with them with shares and linked securities in Lundbeck (Company Announcement No 795).
The original notification stated that 23,666,150 A-shares had been exchanged for a total of DKK 988,771,747.
H. Lundbeck A/S (Lundbeck) has subsequently received a revised notification confirming that 23,689,856 shares were exchanged for a total of DKK 989,762,183.68.
+--+-----------------+----------+-----------+
|1.|Details of the...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
